NCT01696708View on ClinicalTrials.gov

Utilization of 31P-Nuclear Magnetic Resonance Spectroscopy to Monitor Brain Energy Deficit in Huntington Disease

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 6, 2012

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Huntington Disease
Interventions
OTHER

31-Phosphorus RMN Spectroscopy

Trial Locations (1)

75013

Brain and Spine Institute (ICM), Paris

All Listed Sponsors
lead

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

NCT01696708 - Utilization of 31P-Nuclear Magnetic Resonance Spectroscopy to Monitor Brain Energy Deficit in Huntington Disease | Biotech Hunter | Biotech Hunter